PLSM

Pulsenmore Ltd.
CAPPED RATING

Pulsenmore Ltd. (PLSM) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (A-); its weakest is Momentum (D-). The rating has held at C+ for 9 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
C+
Factor Score 2.5 / 5.0
Growth
B+
Factor Score 3.6 / 5.0
Profitability
A-
Factor Score 3.9 / 5.0
Momentum
D-
Factor Score 0.9 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA N/A
Rev Growth YoY 52.0%
Gross Margin 81.8%
Price Return 3M -52.3%
Price Return 12M -81.3%
Catalyst Signal 0.00
Market Cap $9.0M
TTM Revenue N/A
Price / Sales N/A
ROE -45.2%

Historical Factor Score Progression

Held C+ for 9 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 C+ (2.5) B+ (3.6) A- (3.9) D- (0.9) C+ (2.6) C+ (2.7)
2026-11-07 C+ (2.5) B+ (3.6) A- (3.9) D- (1.0) C+ (2.7) C+ (2.7)
2026-10-31 C+ (2.5) B+ (3.7) A- (3.9) D- (1.1) C+ (2.7) C+ (2.8)
2026-10-24 C+ (2.5) B+ (3.7) A- (3.9) D (1.3) C+ (2.6) C+ (2.8)
2026-10-17 C+ (2.5) B+ (3.7) A- (3.9) D (1.2) C+ (2.6) C+ (2.8)
Page 1 of 4